once a week glp-1 agonist Switching Agonists for MAXIMUM Weightloss How GLP-1 Receptor Agonists Evolved
Description
doi: 10.3389/fendo.2022.1024320 49 GillVKumarVSinghKKumarAKimJJ
Zhu B, Gong N, Fan H, Peng CS, Ding XJ, Jiang Y, Wang YX
In general, tirzepatide tends to produce similar rates of nausea but potentially different patterns of gastrointestinal effects due to its additional GIP receptor activity
Initially, it was a modest tool in the diabetes arsenal: enhanced insulin release, suppressed glucagon, slowed gastric emptying
GLP-1
